ArcherDX and Illumina collaborate on planned in-vitro diagnostic (IVD) tests
Co-marketing partnership to drive awareness of ArcherDX IVD products and increase access to vital genomic information in the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Jan 20
Co-marketing partnership to drive awareness of ArcherDX IVD products and increase access to vital genomic information in the…
13 Jan 20
ProciseDx is a diagnostics company committed to the development and commercialization of a broad portfolio of point-of care…
13 Jan 20
Data quantifying the benefit of Sera’s PreTRM strategy submitted for scientific review
10 Jan 20
Provista is engaged in the development of blood-based proteomic diagnostic, prognostic and monitoring tests
10 Jan 20
Element intends to use the funds to speed the development of its low-cost, and easy-to-use genomic sequencing solutions
10 Jan 20
The Flow Re-Direction Endoluminal Device (FRED) System is indicated for use in the internal carotid artery from the…
10 Jan 20
The PSP test on the abioSCOPE can diagnose sepsis 24 hours earlier than today’s standard of care for…
09 Jan 20
The test is said to apply a novel cancer marker to improve the accuracy and sensitivity of non-invasive…
08 Jan 20
Sebia will develop the test and act as worldwide supplier
08 Jan 20
Mobidiag is harnessing the power of its Novodiag platform to develop a fast, simple and reliable syndromic assay…